Dabigatran Etexilate 150mg - Uses, Side Effects, and More
DABIGATREX 150 is a highly effective anticoagulant medication that contains Dabigatran Etexilate (150mg) as its active ingredient. It is primarily used for the prevention and treatment of blood clots in various conditions, including atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). DABIGATREX 150 works by inhibiting thrombin, a key enzyme in the formation of blood clots. Below is an in-depth look at the composition, benefits, usage, and key features of DABIGATREX 150.
Introduction to DABIGATREX 150
DABIGATREX 150 is a novel oral anticoagulant (NOAC) that offers an alternative to traditional blood thinners like warfarin. Its active ingredient, Dabigatran Etexilate, is a direct thrombin inhibitor, which means it directly blocks the action of thrombin, an enzyme involved in the clotting process. This action helps to prevent the formation of harmful clots that can cause severe complications such as stroke, heart attack, and deep vein thrombosis (DVT).
Unlike older anticoagulants, DABIGATREX 150 does not require regular monitoring of blood levels, making it a more convenient option for patients. It provides reliable and consistent anticoagulation effects, reducing the risk of serious clot-related events.
Key Features and Ingredients of DABIGATREX 150
Dabigatran Etexilate (150mg)
- Dabigatran Etexilate is a prodrug that, after oral administration, is rapidly converted in the body to its active form, dabigatran. Dabigatran directly inhibits thrombin, which plays a central role in blood clotting. By inhibiting thrombin, Dabigatran prevents the formation of fibrin, a protein that is essential for clot development. This results in a reduced risk of unwanted clot formation in conditions like atrial fibrillation or venous thromboembolism (VTE).
Mechanism of Action
- As a direct thrombin inhibitor, Dabigatran works differently from warfarin, which interferes with vitamin K-dependent clotting factors. By blocking thrombin, DABIGATREX 150 provides a more targeted approach to anticoagulation therapy, reducing the likelihood of clotting complications.
Usage of DABIGATREX 150
DABIGATREX 150 is typically prescribed for individuals who need to prevent or treat blood clotting disorders. It is essential to follow the prescribed dosage and usage instructions to ensure its effectiveness and safety.
Indications:
- Prevention of Stroke: DABIGATREX 150 is commonly prescribed for the prevention of stroke in patients with non-valvular atrial fibrillation (AF), a condition where the heart\'s irregular rhythm increases the risk of blood clots forming, which can travel to the brain and cause a stroke.
- Treatment of Deep Vein Thrombosis (DVT): It is used to treat DVT, a condition where blood clots form in the deep veins, typically in the legs. DABIGATREX 150 helps to dissolve the clots and prevent new ones from forming.
- Pulmonary Embolism (PE): This medication is also used to treat pulmonary embolism, where a clot from the leg or other parts of the body travels to the lungs and obstructs blood flow.
- Prevention of Recurrence: After initial treatment for DVT or PE, DABIGATREX 150 is used to prevent the recurrence of blood clots.
Dosage: The typical recommended dosage of DABIGATREX 150 is one tablet taken twice daily. It is important to take the medication at the same time every day to maintain consistent levels of the drug in the body.
Administration: DABIGATREX 150 tablets should be taken orally, with or without food. They should be swallowed whole with a glass of water and should not be broken, crushed, or chewed.
Benefits of DABIGATREX 150
Effective Stroke Prevention
- DABIGATREX 150 is highly effective in preventing stroke in patients with non-valvular atrial fibrillation. It reduces the risk of blood clots forming in the heart, which could travel to the brain and cause a stroke. By directly inhibiting thrombin, it provides targeted protection.
Convenient and Easy to Use
- Unlike older anticoagulants like warfarin, DABIGATREX 150 does not require regular blood tests to monitor its effects. This makes it a more convenient choice for patients who need long-term anticoagulation therapy. Patients do not need to adjust their diet or monitor their vitamin K intake, as they would with warfarin.
No Routine Blood Monitoring
- DABIGATREX 150 offers the benefit of not requiring INR (International Normalized Ratio) monitoring, which is necessary for warfarin users. This reduces the need for frequent doctor visits and blood tests, making it easier for patients to manage their treatment.
Reduced Risk of Major Bleeding Events
- Clinical studies have shown that DABIGATREX 150 has a lower risk of causing major bleeding events compared to traditional anticoagulants like warfarin. While bleeding is still a risk, the medication’s predictable anticoagulation effect reduces the chances of uncontrolled bleeding.
Rapid Onset of Action
- DABIGATREX 150 has a rapid onset of action, meaning it starts working quickly after ingestion. This is especially beneficial in emergency situations or when immediate anticoagulation is needed.
Treatment for Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
- DABIGATREX 150 is highly effective in treating DVT and PE, both of which are potentially life-threatening conditions caused by blood clots. It prevents the formation of new clots while helping to dissolve existing ones, thus reducing the risk of complications such as pulmonary embolism.
Prevention of Clot Recurrence
- After initial treatment for DVT or PE, DABIGATREX 150 is used to prevent further clot formation, reducing the risk of recurrent blood clots.
Conclusion
DABIGATREX 150, with its active ingredient Dabigatran Etexilate (150mg), is a highly effective and convenient option for patients requiring anticoagulation therapy. It is used for the prevention of stroke, treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE), offering a reliable and predictable anticoagulation effect.Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma\'s product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
